跳至主要内容
临床试验/CTRI/2014/08/004931
CTRI/2014/08/004931已完成2 期

A CLINICAL STUDY ON AZHAL KALLADAIPPU (RENAL CALCULI)AND THE DRUG OF CHOICCE IS IRUKAARA PARPAM (INTERNAL).

ATIONAL INSTITUTE OF SIDDHA0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients who are having the classical symptoms of abdominal pain and distensión, pain from loin to groin, pain in urethra, agonizing pain, dysuria, oliguria, yellow coloured urination, burning micturition, haematuria, nausea and vomiting.
  • Stone size: >=4mm and <=10mm
  • Patient with renal calculus detected on X-ray KUB or USG abdomen.
  • History of Recurrence of Renal calculi.
  • Patient willing to sign the informed consent stating that he/she will conscientiously stick to the treatment during 24days but can opt out of the trial of his/her own conscious discretion.
  • Patients who are willing to take Ultrasonography Investigation (USG- abdomen / KUB) and provide blood and urine samples for laboratory investigation.

排除标准

  • Stone size 10mm
  • Pregnancy and lactation
  • Presence of any associated severe systemic illness, e.g.CA
  • Patient taking any other lithotriptic agent in the recent past
  • History of Diabetes/ Hypertension
  • Renal diseases
  • Cardiac diseases

研究者

相似试验